Use of nivolumab for colon cancer with Lynch syndrome
Lynch syndrome (LS), which occurs as a result of the defects in DNA mismatch repair, is characterized by an increased risk of colon, endometrial and urinary tract cancers. It is known that in case of colorectal cancer, the presence of high-frequency microsatellite instability (MSI-H) is associated w...
Enregistré dans:
Auteurs principaux: | G. A. Khakimov, A. A. Tryakin, G. G. Khakimova |
---|---|
Format: | article |
Langue: | RU |
Publié: |
IP Habib O.N.
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b99da209ccc44f37985e2d2943ad2e92 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pathological Complete Response of Clinical T4b Ascending Colon Cancer after Preoperative Chemotherapy Using Pembrolizumab
par: Terufumi Yoshida, et autres
Publié: (2021) -
New targeted treatments for non-small-cell lung cancer – role of nivolumab
par: Zago G, et autres
Publié: (2016) -
Hodgkin lymphoma. ASCO, EHA and ASH 2020 news
par: Elena A. Demina
Publié: (2021) -
The Continuum of Thyroid Disorders Related to Immune Checkpoint Inhibitors: Still Many Pending Queries
par: Maria V. Deligiorgi, et autres
Publié: (2021) -
New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab
par: Seetharamu N, et autres
Publié: (2017)